Dropdown

EE - Estonia
All companies
    All persons

      Search word:

      Field/EMTAK

      AIM PHARMA OÜ

      Media page and news feed
      ?
      ?
      profile visits
      924
      ?
      company tracker
      26
      This company's branding has already reached 924 peopleand his is followed by 26 Storybook users.On average, the company has been rated 2.8 points.but there is n

      AIM PHARMA OÜ current status

      2184939_andmerobot_99391772_a_xl.jpg
      Andmerobot
      Did you notice typos in the article?

      Dropdown

      This company's branding has already reached 924 peopleand his is followed by 26 Storybook users.On average, the company has been rated 2.8 points.but there is no comment.

      Tegevusaruanne 2024

      AIM Pharma OÜ asutati 2012.aastal.

      2024 majandusaasta jooksul majandustegevust oli Spetsialiseerimata hulgikaubandus

      Põhieesmärgid on järgmised: turupositsiooni säilitamine ning kindlustamine olemasolevatel turudel; uute klientide, turgude leidmine

      Comments (0)

      Are you sure you want to delete this article?

      Dropdown

      all articles

      File a complaint

      Choose the comment attribute that you think it contains:

      False information
      Spam
      Hate speech
      Terrorism
      Other

      You want to report an inappropriate comment.

      Are you sure?

      Are you sure you want to delete this article?

      Loader

      Loader

      App Ad

      Scorestorybook Chrome extension

      The Storybook extension tells you which company's website you are currently on and how reliable that company is today. download extension

      See the background of the caller! Storybook App brings you direct contacts for 400,000 Estonian companies and individuals (managers, officials). The data is enriched with solvency and financial information.

      We value your privacy

      We use cookies to improve your browsing experience, provide personalized ads or content, and analyze our traffic. By clicking "allow all", you agree to our use of all cookies.